ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms

May 26, 1995

CCIRC Report Suggests Ways To Enhance Role Of Surgeons

July 22, 1977

Mendelsohn To Step Down As MD Anderson President

December 10, 2010